Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

R. Corre | Researchclopedia

Back to researchers

R. Corre

Centre Hospitalier de Saint-Brieuc ORCID

173

Works

9,917

Citations

24

h-index

50

i10-index

Research Topics

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment

Affiliations

Fidal2012–2012

Inserm2018–2024

Université de Bretagne Occidentale2018–2018

Assistance Publique Hôpitaux de Marseille2014–2014

Oncogenesis Stress Signaling2017–2024

Top Works

Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial

Rafael Rosell,Enric Carcereny,et al.

20125,500 citations

Lung Cancer Research Studies

Colorectal Cancer Treatments and Studies

Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trial

Gérard Zalcman,Julien Mazières,et al.

2015968 citations

Nivolumab or nivolumab plus ipilimumab in patients with relapsed malignant pleural mesothelioma (IFCT-1501 MAPS2): a multicentre, open-label, randomised, non-comparative, phase 2 trial

Arnaud Scherpereel,Julien Mazières,et al.

2019453 citations

Use of a Comprehensive Geriatric Assessment for the Management of Elderly Patients With Advanced Non–Small-Cell Lung Cancer: The Phase III Randomized ESOGIA-GFPC-GECP 08-02 Study

R. Corre,Laurent Greillier,et al.

2016403 citations

Bevacizumab in Patients With Hereditary Hemorrhagic Telangiectasia and Severe Hepatic Vascular Malformations and High Cardiac Output

Sophie Dupuis‐Girod,Isabelle Ginon,et al.

2012382 citations

Association of<i>EGFR</i>L858R Mutation in Circulating Free DNA With Survival in the EURTAC Trial

Niki Karachaliou,Clara Mayo-de las Casas,et al.

2015235 citations

Nivolumab plus ipilimumab versus chemotherapy as first-line treatment in advanced non–small-cell lung cancer with high tumour mutational burden: patient-reported outcomes results from the randomised, open-label, phase III CheckMate 227 trial

Martin Reck,Michael Schenker,et al.

2019215 citations

Pulmonary Arteriovenous Malformations in Hereditary Hemorrhagic Telangiectasia

Vincent Cottin,Thierry Chinet,et al.

2007214 citations

Parallel FISH and Immunohistochemical Studies of ALK Status in 3244 Non–Small-Cell Lung Cancers Reveal Major Discordances

Florian Cabillic,Audrey Gros,et al.

2014150 citations